Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway.

MLA

Hsu, Jui-Ling, et al. “Doxazosin Inhibits Vasculogenic Mimicry in Human Non‑small Cell Lung Cancer through Inhibition of the VEGF‑A/VE‑cadherin/MTOR/MMP Pathway.” Oncology Letters, vol. 27, no. 4, Apr. 2024, p. N.PAG. EBSCOhost, https://doi.org/10.3892/ol.2024.14303.

APA

Hsu, J.-L., Leu, W.-J., Hsu, L.-C., Hsieh, C.-H., & Guh, J.-H. (2024). Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway. Oncology Letters, 27(4), N.PAG. https://doi.org/10.3892/ol.2024.14303

Chicago

Hsu, Jui-Ling, Wohn-Jenn Leu, Lih-Ching Hsu, Chia-Hsun Hsieh, and Jih-Hwa Guh. 2024. “Doxazosin Inhibits Vasculogenic Mimicry in Human Non‑small Cell Lung Cancer through Inhibition of the VEGF‑A/VE‑cadherin/MTOR/MMP Pathway.” Oncology Letters 27 (4): N.PAG. doi:10.3892/ol.2024.14303.